AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 167 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 20,000 | +5.8% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 18,900 | -45.8% | 0.00% | -100.0% |
| Q1 2022 | $17,000 | +325.0% | 34,900 | -3.9% | 0.00% | – |
| Q1 2021 | $4,000 | +100.0% | 36,300 | +16.7% | 0.00% | – |
| Q4 2020 | $2,000 | -60.0% | 31,100 | +14.8% | 0.00% | – |
| Q3 2020 | $5,000 | -95.0% | 27,100 | +68.3% | 0.00% | -100.0% |
| Q2 2020 | $101,000 | +288.5% | 16,100 | +56.3% | 0.01% | +500.0% |
| Q4 2019 | $26,000 | 0.0% | 10,300 | -15.6% | 0.00% | -50.0% |
| Q3 2018 | $26,000 | -33.3% | 12,200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $39,000 | +387.5% | 12,200 | +16.2% | 0.00% | – |
| Q4 2017 | $8,000 | – | 10,500 | +5.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |